Bill Texts: WA SB6127 | 2023-2024 | Regular Session

Bill Title: Increasing access to human immunodeficiency virus postexposure prophylaxis drugs or therapies.

Spectrum: Moderate Partisan Bill (Democrat 8-2)

Status: (Passed) 2024-03-25 - Effective date 1/1/2025. [SB6127 Detail]

Bill Drafts

RevisionDateFormatSourceView
Chaptered2024-03-29PDFLinkView
Enrolled2024-03-05PDFLinkView
Engrossed2024-02-07PDFLinkView
Comm Sub2024-01-29PDFLinkView
Introduced2024-01-09PDFLinkView

Amendments

AmendmentDateDispositionFormatSourceView
House Committee Amendment2024-02-21ProposedPDFLinkView
Senate Floor Amendment2024-02-07ProposedPDFLinkView

Supplemental Documents

TitleDescriptionDateFormatSourceView
MiscSenate Bill Report (Orig.)2024-01-15PDFLinkView
Fiscal Note6127 SB (Final)2024-01-22PDFLinkView
MiscSenate Bill Report2024-01-26PDFLinkView
MiscEngrossed Substitute Senate Bill Report2024-02-07PDFLinkView
MiscEngrossed Substitute House Bill Analysis 20242024-02-13PDFLinkView
Fiscal Note6127 ESSB (Final)2024-02-15PDFLinkView
MiscEngrossed Substitute House Bill Report2024-02-23PDFLinkView
MiscEngrossed Substitute House Bill Report2024-02-27PDFLinkView
MiscEngrossed Substitute Senate Bill Report2024-02-27PDFLinkView
Fiscal Note6127 SB 6127-S.E AMH HCW H3294.2 (Final)2024-02-27PDFLinkView
MiscFinal Bill Report2024-03-05PDFLinkView

Social Comments on WA SB6127

feedback